Stock Price
20.48
Daily Change
-0.20 -0.97%
Monthly
-19.08%
Yearly
-22.01%
Q1 Forecast
19.91

Pacira reported $0.7 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.91 0.91 Feb/19 2026
FY2025Q3 Sep/2025 0.70 0.66 0.79 Nov/06 2025
FY2025Q2 Jun/2025 0.74 0.68 0.89 Aug/05 2025
FY2025Q1 Mar/2025 0.62 0.61 0.62 May/08 2025
FY2024Q4 Dec/2024 0.91 0.79 0.89 Feb/27 2025




Eps Change Date
Astellas Pharma JPY 56.04 11.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Ironwood Pharmaceuticals USD 0.24 0.1 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.8 1.2 Sep/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025
Zoetis USD 1.7 0.06 Sep/2025